Product
Supplier
Encyclopedia
Inquiry
API Apremilast buy - large image1
API Apremilast buy - image1

API Apremilast

2 Inquiries

Unit Price: Get Latest Price
CAS No.:

608141-41-9

Grade:

Pharmaceutical Grade

Content:

99%

Port:

shanghai

Brand:

Hyper Chem

Packaging:

20kg/Drum 25kg/Drum

Sample Available:

Yes

Price valid (until):

2025-12-27

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
10 days
Qualification:
Main Products:

Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Name

    Apremilast

    CAS number

    608141-41-9

    Description

    Apremilast, also known as CC-10004, is a thalidomide analog and is an orally available small molecule inhibitor of phosphodiesterase 4 (PDE4). Apremilast specifically inhibits PDE4 and inhibits spontaneous production of TNF-alpha from human rheumatoid synovial cells. It has anti-inflammatory activity. Apremilast was approved by the USFDA in March 2014 for treatment of adults with active psoriatic arthritis. It is also being tested for its efficacy in treating other chronic inflammatory diseases such as ankylosing spondylitis, Behcet's disease, and rheumatoid arthritis

    Synonym

    CC10004; CC-10004; CC 10004; Apremilast; brand name: Otezla.

    Appearance

    Solid powder

    Quality Standard

    USP, EP, BP, CP

    Shipping Condition

    Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

    Storage Condition

    Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

    Shelf Life

    >2 years if stored properly

    Sample package

    Aluminium foil bag

    Commercial package

    Aluminium Tin, Fiber drum

    Origin

    China


    Apremilast More Info

    1. Basic Information

    Generic Name: Apremilast

    CAS Number: 608141-41-9

    Molecular Formula: C₂₂H₂ 4 N₂O₇S

    Molecular Weight: 460.50 g/mol

    Mechanism of Action: A selective phosphodiesterase 4 (PDE4) inhibitor that regulates inflammation by increasing intracellular cyclic adenosine monophosphate (cAMP) levels, suppressing pro-inflammatory cytokines (e.g., TNF-α, IL-17) and enhancing anti-inflammatory factors (e.g., IL-10).

    2. Key Applications

    Indications: Approved for treating:

    Plaque psoriasis (adult patients)

    Psoriatic arthritis (adult patients)

    Oral ulcers associated with Behçet’s disease (adult patients)

    Formulation: Oral tablets (10 mg, 20 mg, 30 mg strengths); R&D in topical formulations (e.g., creams) is ongoing.

    3. Commercial & Quality Highlights

    Market Status: First approved by the FDA (U.S.) in 2014, EMA (EU) in 2015, and NMPA (China) in 2019; marketed globally under the brand name "Otezla" (Celgene, a Bristol Myers Squibb company).

    Quality Standards: Complies with USP, EP, BP, and CP pharmacopoeial requirements; suitable for API manufacturing of generic drugs.

    Key Advantages:

    Oral administration (convenient vs. injectable biologics for psoriasis/arthritis).

    No immunosuppressive effects (lower infection risk).

    Well-tolerated with mild adverse reactions (mostly gastrointestinal, e.g., diarrhea, nausea, which are transient).

    4. API Supply & Trade Notes

    Manufacturing Capacity: Global API production is concentrated in India, China, and Europe; bulk supply available with GMP certification.

    Trade Considerations:

    Regulatory: Requires compliance with import/export regulations for pharmaceutical ingredients (e.g., DMF filing, CEP certificate for EU market).

    Stability: Store in sealed containers, protected from light and moisture; shelf life typically 2–3 years.


    Shop API Apremilast-Detailed Image 1

    ECHEMI Editorial Reference
    Apremilast is an orally available inhibitor of type-4 cyclic nucleotide phosphodiesterase (PDE-4) with an IC50 of 74 nM.
    Apremilast is a member of the class of isoindoles that is isoindole-1,3-dione substituted at position 4 by an acetamido group and at position 1 by a 1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl group. Used for treatment of psoriatic arthritis. It has a role as a phosphodiesterase IV inhibitor and a non-steroidal anti-inflammatory drug. It is an aromatic ether, a N-acetylarylamine, a sulfone and a member of phthalimides.|Apremilast, also known as Otezla, is a phosphodiesterase 4 (PDE4) inhibitor used to treat various types of symptoms resulting from certain inflammatory autoimmune diseases. It belongs to the same drug class as [Roflumilast] and [Crisaborole]. Initially approved in 2014, it is marketed by Celgene. In July 2019, apremilast was granted a new FDA approval for the treatment of oral ulcers associated with Behcet's disease, an autoimmune condition that causes recurrent skin, blood vessel, and central nervous system inflammation.|Apremilast is an orally available, small molecule inhibitor of phosphodiesterase-4 (PDE-4) and an immunomodulating agent that is used for treatment of refractory psoriatic arthritis. Apremilast has been linked to a low rate of serum enzyme elevations during therapy, but has not been implicated in cases of clinically apparent acute liver injury.|Apremilast is an orally bioavailable, small molecule inhibitor of phosphodiesterase 4 (PDE4), with potential anti-inflammatory activity. Upon oral administration, apremilast targets, binds to and inhibits the activity of PDE4, thereby blocking cyclic adenosine monophosphate (cAMP) degradation and increasing intracellular cAMP levels. This may decrease the production of the proinflammatory cytokines including tumor necrosis factor-alpha (TNF-alpha). PDE4 is an enzyme that plays an important role in the degradation of cAMP and in cytokine production in inflammatory cells.

    Basic Info
    Product Name:

    Apremilast

    Other Name:

    Acetamide,N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]-;N-[2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]acetamide;(S)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione;Apremilast;CC 10004;(S)-N-[2-[1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl]ethyl]-1,3-dioxoisoindolin-4-yl)acetamide;Otezla;666854-78-0

    CAS No.:

    608141-41-9

    Molecular Formula:

    C22H24N2O7S

    InChIKeys:

    InChIKey=IMOZEMNVLZVGJZ-QGZVFWFLSA-N

    Molecular Weight:

    460.50000

    Exact Mass:

    460.50

    UNII:

    UP7QBP99PN

    NCI Thesaurus Code:

    C147044

    ATC Code:

    L04AA32|L - Antineoplastic and immunomodulating agents

    Categories:

    Other Chemical Drugs

    Characteristics
    PSA:

    127.46000

    XLogP3:

    3.52590

    Density:

    1.381

    Melting Point:

    156.1

    Boiling Point:

    741.3±60.0

    Flash Point:

    402.1±32.9 °C

    Refractive Index:

    1.612

    Water Solubility:

    In water, 225.4 mg/L at 25 deg C (est)

    Storage Conditions:

    Store tablets below 30 deg C (86 deg F).

    Vapor Pressure:

    3.63X10-19 mm Hg at 25 deg C (est)

    PKA:

    12.58None

    Henrys Law Constant:

    Henry's Law constant = 3.99X10-22 atm-cu m/mol at 25 °C (est)

    Dissociation Constants:

    pKa1 = 12.58 (amide) (est)

    Hazard Identification

    Classification of the substance or mixture

    Acute toxicity - Category 4, Oral

    Reproductive toxicity, Category 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H302 Harmful if swallowed

    H361 Suspected of damaging fertility or the unborn child

    Precautionary statement(s)
    Prevention

    P264 Wash ... thoroughly after handling.

    P270 Do not eat, drink or smoke when using this product.

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P301+P317 IF SWALLOWED: Get medical help.

    P330 Rinse mouth.

    P318 IF exposed or concerned, get medical advice.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements

    Location:

    Rm. 803, Tower 4, LOFT49 Creative City Pioneer Zone, No.88 Jiru Rd. Gongshu Dist., Hangzhou, 310015 ZJ, China

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    10 days

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    11-50

    Year of Establishment:

    2013

    Company Certificates
    • Hangzhou Hyper Chemicals LimitedCertification Report by Bureau Veritas Certification Report by Bureau Veritas
    About HyperChem

    Established in 2013, Hyper Chem has exclusive tie-ups with leading manufacturers, supplying raw materials produced in GMP and ISO 9002 certified facilities, and provides high-quality ingredients and raw materials to meet the needs of a diverse range of pharmaceutical cosmetics ingredients and nootropic supplements companies worldwide.

    Our Competitiveness

    One-stop supply

    Wide Range Of products including pharmaceutical, Cosmetic Ingredients and nootropic supplements

    Among all the pharmaceuticals,

    90% of them with GMP certificates,

    85% of them with DMF files and

    50% of them passed FDA approval,

    30% get CEP certificate

    20% are new R&D products.

    Custom Repackaging Service


    We can efficiently repackage your material into sample sizes, custom batch-specific sizes, or semi-bulk package sizes according to your specifications. And ensures the product is packaged in a quality-controlled environment and will maintain its integrity throughout every stage of the process.

    Quality Control/Quality Assurance


    HyperChem is committed to delivering on its promises of top-quality products with verified quality data.

    All materials are vigorously inspected by the factory and/or outsourced analytical laboratories to ensure each and every lot meets or exceeds our reference standards.

    Trade assurance service with 100% payment protection, It is best achieved by delivering products and services 100% right the first time, on time, every time.

    Professional

    Transparent Communication

    Fast Reaction,

    Professional Suggestion

    Beyond Expectation.

    We have exclusive partnerships with research and production facilities across the country and we offer varied pharmaceutical services in the most cost-efficient way. The production facilities are GMP, WHO-GMP, EU GMP and US FDA approved and are backed by strong regulatory support such as Dossier, DMF, Tech Pack and relevant Stability studies for regulatory filings.

  • Inquiry History
    2 Inquiries
    Country Product Purchase Quantity Date Posted
    Pakistan

    APREMILAST

    10 KG Jan 14, 2026
    India

    Bortezomib

    100.00 G Jul 30, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.